Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Adma Biologics (ADMA) Other Non-Current Liabilities (2016 - 2025)

Adma Biologics' Other Non-Current Liabilities history spans 13 years, with the latest figure at $90000.0 for Q3 2025.

  • For Q3 2025, Other Non-Current Liabilities fell 76.0% year-over-year to $90000.0; the TTM value through Sep 2025 reached $90000.0, down 76.0%, while the annual FY2024 figure was $360000.0, 14.08% down from the prior year.
  • Other Non-Current Liabilities reached $90000.0 in Q3 2025 per ADMA's latest filing, up from $2000.0 in the prior quarter.
  • In the past five years, Other Non-Current Liabilities ranged from a high of $768538.0 in Q1 2021 to a low of $2000.0 in Q1 2025.
  • Average Other Non-Current Liabilities over 5 years is $324858.2, with a median of $373903.0 recorded in 2022.
  • Peak YoY movement for Other Non-Current Liabilities: surged 934.28% in 2022, then tumbled 99.51% in 2025.
  • A 5-year view of Other Non-Current Liabilities shows it stood at $397351.0 in 2021, then fell by 11.92% to $350000.0 in 2022, then increased by 19.71% to $419000.0 in 2023, then decreased by 14.08% to $360000.0 in 2024, then crashed by 75.0% to $90000.0 in 2025.
  • Per Business Quant, the three most recent readings for ADMA's Other Non-Current Liabilities are $90000.0 (Q3 2025), $2000.0 (Q2 2025), and $2000.0 (Q1 2025).